Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This summary needs review. Please check the official study record and contact the research team for details.
In La Jolla
This study is looking at care and outcomes for people with depression. Taking part may give some people access to Nervio-X, but direct benefit is not guaranteed.
In ShanghaiThis study is looking at care and outcomes for people with depression. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
In ShanghaiThis summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Shanghai
This summary needs review. Please check the official study record and contact the research team for details.
In Belgium
This study was terminated in Finland, in Hungary, in Czechia, .... It focuses on anxiety.
In FinlandThis study is completed in Czechia. It focuses on Anxiety.
In Czech RepublicThis study is completed in Hungary and in Bulgaria. It is testing Armodafinil Treatment (150 mg/day) for Bipolarity.
In HungaryThis study is completed in the United Kingdom, in Ireland, in Sweden, .... It is testing Pregabalin (300-600 mg/day) and Venlafaxine XR (75-225 mg/day) for Anxiety.
In IrelandThis study is completed in Romania and in Outside EU/EEA. It focuses on schizophrenia.
In RomaniaThis study exists to learn from real-world information that can show how the medication Unflavored fits into care. Researchers are trying to understand how people respond to the medication Unflavored in practice and what may need to be adjusted.
Location not clearly listedThis study is completed in the United Kingdom. It focuses on anxiety.
In NorwichHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.